CoreWeave (CRWV) CDO-linked GRATs convert and sell Class A stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CoreWeave, Inc.’s Chief Development Officer McBee Brannin reported indirect trust transactions in Class A and Class B shares on January 26, 2026. Canis Major 2025 GRAT and Canis Minor 2025 GRAT converted Class B Common Stock into Class A Common Stock and then sold Class A shares in multiple open‑market trades.
The sales were made under a Rule 10b5‑1 trading plan adopted on September 2, 2025, at weighted average prices with ranges from about $98.18 to $108.54 per share, as described in the footnotes. The filing also shows significant indirect holdings of Class B Common Stock in the two GRATs and additional indirect ownership through the reporting person’s spouse and child.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 33,335 shares ($3,381,893)
Net Sell
26 txns
Insider
McBee Brannin
Role
Chief Development Officer
Sold
33,335 shs ($3.38M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Class B Common Stock | 25,000 | $0.00 | -- |
| Conversion | Class B Common Stock | 8,335 | $0.00 | -- |
| Conversion | Class A Common Stock | 25,000 | $0.00 | -- |
| Sale | Class A Common Stock | 7,007 | $98.5766 | $691K |
| Sale | Class A Common Stock | 2,063 | $99.9125 | $206K |
| Sale | Class A Common Stock | 2,922 | $100.7953 | $295K |
| Sale | Class A Common Stock | 6,209 | $101.6689 | $631K |
| Sale | Class A Common Stock | 1,207 | $102.5471 | $124K |
| Sale | Class A Common Stock | 1,602 | $104.2838 | $167K |
| Sale | Class A Common Stock | 1,767 | $105.0301 | $186K |
| Sale | Class A Common Stock | 1,238 | $106.2332 | $132K |
| Sale | Class A Common Stock | 731 | $107.1005 | $78K |
| Sale | Class A Common Stock | 254 | $107.9936 | $27K |
| Conversion | Class A Common Stock | 8,335 | $0.00 | -- |
| Sale | Class A Common Stock | 2,336 | $98.5765 | $230K |
| Sale | Class A Common Stock | 688 | $99.9121 | $69K |
| Sale | Class A Common Stock | 975 | $100.7955 | $98K |
| Sale | Class A Common Stock | 2,070 | $101.6692 | $210K |
| Sale | Class A Common Stock | 402 | $102.5479 | $41K |
| Sale | Class A Common Stock | 534 | $104.2841 | $56K |
| Sale | Class A Common Stock | 589 | $105.0301 | $62K |
| Sale | Class A Common Stock | 413 | $106.2332 | $44K |
| Sale | Class A Common Stock | 243 | $107.0993 | $26K |
| Sale | Class A Common Stock | 85 | $107.9912 | $9K |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 5,775,000 shares (Indirect, Canis Major 2025 GRAT);
Class A Common Stock — 25,000 shares (Indirect, Canis Major 2025 GRAT)
Footnotes (1)
- Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.18 to $99.14, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.24 to $100.23, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.24 to $101.23, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.24 to $102.23, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.24 to $103.11, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.71 to $104.70, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.71 to $105.70, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.73 to $106.69, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.74 to $107.65, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.77 to $108.54, inclusive. The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee. The reported securities are directly held of record by the reporting person's child. The reported securities are directly held by the reporting person's spouse.
FAQ
What insider transactions did CoreWeave (CRWV) disclose for January 26, 2026?
CoreWeave reported that trusts associated with Chief Development Officer McBee Brannin converted Class B Common Stock into Class A and then sold Class A shares in multiple open-market transactions on January 26, 2026, all under a pre-arranged Rule 10b5-1 trading plan.
Who is the reporting person in this CoreWeave (CRWV) Form 4 filing?
The reporting person is McBee Brannin, CoreWeave’s Chief Development Officer. The filing shows indirect ownership and transactions primarily through the Canis Major 2025 GRAT, Canis Minor 2025 GRAT, and additional holdings attributed to Brannin’s spouse and child, rather than directly held personal accounts.
What is the role of the Rule 10b5-1 plan in these CoreWeave (CRWV) sales?
A footnote states the reported sales were carried out under a Rule 10b5-1 trading plan adopted on September 2, 2025. Such plans allow predetermined trading instructions, so these transactions were scheduled in advance rather than being discretionary, same-day trading decisions by the insider.
What indirect CoreWeave (CRWV) holdings are reported for the insider’s family?
The filing lists indirect holdings of Class B Common Stock by the reporting person’s spouse and through the Canis Major 2025 GRAT and Canis Minor 2025 GRAT, plus Class A shares held of record by the reporting person’s child. All of these positions are reported as indirect beneficial ownership.